Emerging Targets and Therapeutics in Immuno|Oncology

Emerging Targets and Therapeutics in Immuno-Oncology

We unveil over 300 emerging concepts, depicted in a comprehensive “Trend Landscape Map”. These concepts, spanning therapeutic targets, biomarkers, and types of ...

Emerging Targets and Therapeutics in Immuno-Oncology: Insights ...

We unveil over 300 emerging concepts, depicted in a comprehensive “Trend Landscape Map”. These concepts, spanning therapeutic targets, biomarkers, and types of ...

Emerging Targets and Therapeutics in Immuno-Oncology - PubMed

In the ever-evolving landscape of cancer research, immuno-oncology stands as a beacon of hope, offering novel avenues for treatment.

Emerging Targets and Therapeutics in Immuno-Oncology Landscape

Abstract. Rapid and sustained growth in the field of immuno-oncology has resulted in expansion of available scientific literature. Gaining ...

Emerging Targets and Therapeutics in Immuno-Oncology Landscape

Our analysis led to identification of >300 emerging concepts across major categories such as therapeutic targets, biomarkers, therapies, and types of cancer. We ...

Emerging Immuno-Oncology Targets

While cancer immunotherapy has made a giant leap in the past five years, the majority of therapies at advanced stages of development are clustered in a similar ...

Emerging trends in immunotherapy and cancer - CAS.org

With each new advance, emerging targets and biomarkers that hold the key to exciting IO therapy innovations are being continually uncovered.

Immuno-Oncology- Emerging Targets and Therapeutics

CHI's Inaugural Immuno-Oncology: Emerging Targets and Therapeutics conference will cover newer cell surface targets in the IO field that are being ...

Emerging Tech for IO Targeting and Discovery

Immuno-oncology has completely transformed cancer treatment by leveraging the body's own immune system to combat the disease. However, significant problems ...

Immuno-Oncology: Emerging Targets and Combination Therapies

We cover a range of emerging (“second-generation”) therapies incorporating other immunotherapies or non-immune based strategies in synergistic combination.

Therapeutic targets and biomarkers of tumor immunotherapy - Nature

Immunotherapy aims to reactivate antitumor immune cells and overcome the immune escape mechanisms of tumors. Represented by immune checkpoint ...

Emerging Immuno-Oncology Targets and Modalities

While cancer immunotherapy has made a giant leap in the past five years, the majority of therapies at advanced stages of development are clustered in a ...

Emerging Targets for Oncology and Beyond - 2023 Archive

These include IO-108, an antagonist antibody targeting LILRB2 (ILT4), in Phase I clinical development for solid tumors and IO-202; an antagonist antibody ...

New emerging targets in cancer immunotherapy - ScienceDirect.com

We review an emerging tool for cancer immunotherapy, the so-called neoantigens and discuss their role as targets for cancer vaccines and adoptive T-cell ...

New targets for improved cancer immunotherapy - News-Medical

In the past two decades, immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, showing promising results against various ...

Emerging Therapeutic Targets and Drug Resistance Mechanisms in ...

B7-H3 is a key target for cancer immunotherapy through its expression on tumor cells and correlates with poor clinical outcomes [118,119]. Also, the B7-H4 ...

Emerging Targets for Oncology and Beyond - PEGS Boston

Join the Emerging Targets for Oncology and Beyond conference and discover the latest therapeutic candidates against emerging or new-again targets for drug ...

Neoantigens: promising targets for cancer therapy - Nature

Based on their advantages of tumor-specific and immunogenetic, neoantigens may serve as emerging targets for cancer immunotherapies, including ...

Finding Common Cause to Advance Immunotherapy Access with ...

These translational research platforms, described in Nature Medicine in March 2022, are intended to guide new treatment regimens by fostering highly productive ...

Small Molecules for Cancer Targets | Sept 30 - Oct 3, 2024

Join CHI's Small Molecules for Cancer Targets conference to hear progress in potential new small molecule-based cancer therapeutics against novel drug targets.